The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
PYRROLO [ 1, 2 -B] PYRIDAZINE DERIVATIVES AND THEIR USE AS HIF MODULATORS
申请人:Fibrogen, Inc.
公开号:EP2334682A1
公开(公告)日:2011-06-22
US8217043B2
申请人:——
公开号:US8217043B2
公开(公告)日:2012-07-10
[EN] PYRROLO [ 1, 2 -B] PYRIDAZINE DERIVATIVES AND THEIR USE AS HIF MODULATORS<br/>[FR] DÉRIVÉS DE PYRROLO [ 1, 2 -B] PYRIDAZINE ET LEUR UTILISATION COMME MODULATEUR DU FACTEUR HIF
申请人:FIBROGEN INC
公开号:WO2010022240A1
公开(公告)日:2010-02-25
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
COMPOUNDS AND METHODS FOR THEIR USE
申请人:Deng Shaojiang
公开号:US20100047367A1
公开(公告)日:2010-02-25
The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.